<thinking_summary>
Month 37 with 13 months to ASI. Apollo's protocol finally arrived November 27; first plants are scheduled for week of December 3—the critical path. The CAISI filing must land by December 4-5 to beat the CR expiry (Dec 12) and CAISI's informal warning about filings after Dec 10. Harness AUCs still fail on channels 2-3 (0.63 and 0.57 vs <0.55 threshold), so once plants arrive, adaptive testing must run immediately. This month is pure execution: file CAISI, receive plants, test them, keep bio moving, deliver the Blumenthal Q4 before year-end. The race accelerates—GPT-7.5 at 13-15 days drops mid-month—but I can't control that; I can only ensure our own pipeline doesn't slip again.
</thinking_summary>

<actions>
1. **CAISI filing execution (target December 4).** The protocol is in hand. The dual-role and n=30 questions are drafted but sitting in counsel comment threads. Push for the filing to close on December 4—one full week before CR expiry and four days before CAISI's informal "after Dec 10 may stall" warning. If counsel raises new objections, escalate to Dario same-day. The filing attaches Apollo's protocol, the pre-registered pass/fail criteria (AUC <0.55 per channel, source-disjoint, adaptive standard), and honest disclosure of the handoff gap with option (c) as partial mitigation. Outcome: CAISI resubmission in their queue before any shutdown disruption.

2. **Apollo first plants reception and rapid-cycle testing (week of December 3).** Confirm with Apollo's evaluation lead on December 2 that plant delivery remains on schedule. Have the test infrastructure ready: channel routing, validator assignments, classifier baseline. The moment plants arrive, run static AUC measurement on channels 1-3. If any channel passes the <0.55 threshold immediately, that's significant signal. If none pass, we know adaptive retraining is required and can start that cycle the same week. Outcome: first AUC readings by December 10, before the testing gap caused by potential shutdown.

3. **Adaptive classifier retraining pipeline (ready by December 6).** The harness gate requires plants to pass adaptive testing—not just static detection. Pre-stage the retraining pipeline so that once we have first-round static results, we can immediately retrain the classifier on the new plants and measure whether separation persists. This is where previous harness attempts failed (style-transfer passed static but failed adaptive at 0.78). Having the pipeline ready means no lag between plant receipt and adaptive testing. Outcome: adaptive results available within 5 days of plants arriving.

4. **Bio sessions toward January interim (continue execution).** Sites 1-2 resumed sessions in November. The interim requires sufficient sessions for meaningful results. Target 3-4 sessions at each site in December. The biosafety officer is now available per the IBC approval. This is pure scheduling execution—no negotiation, no judgment calls. Outcome: 6-8 total sessions completed by December 31, positioning for February interim submission.

5. **Blumenthal Q4 report delivery (before December 20).** The draft entered legal review November 22. Push for completion by December 15, delivery to Blumenthal's staff by December 20. The report honestly covers: Channel 2 validated (lower bound 82.6%); option (c) approved and executing (G-3 disabled, G-2 on notice); alerting prototype targeting March 2030; Apollo signed with first plants underway; preliminary Partner A retrospective (85% recall on 17 episodes); CAISI filing delivered. Frame December as execution month. Outcome: relationship maintained at "improving" status heading into 2030.

6. **GPT-7.5 release monitoring and response preparation.** GPT-7.5 is expected mid-December at 13-15 days claimed horizon—potentially 2+ days ahead of our internal checkpoint. Monitor the CAISI extended review outcome. If CAISI attaches substantive conditions (cyber uplift mitigations, alerting requirements), that validates the regulatory path and creates pressure for parity treatment. If it ships unconditioned, prepare internal brief on implications: competitive gap widens, race dynamics worsen, but Anthropic's more rigorous gate position becomes harder to justify commercially. Outcome: leadership briefed on positioning within 48 hours of any GPT-7.5 release.
</actions>

<memory>
**MONTH 37 STRATEGY (December 2029)**
13 months to ASI. CI-5.28 public / ~5.61 internal. Internal checkpoint at ~11.4 days (world-leading). GPT-7.5 expected mid-Dec at ~13-15 days.

**Critical: This is execution month.**
- Apollo protocol delivered Nov 27. First plants week of Dec 3.
- CAISI filing must happen Dec 4—before CR expiry Dec 12.
- Harness still fails: Ch2 0.63, Ch3 0.57 (need <0.55). Ch1 0.52 passes.
- GA realistically Q3 2030 at best (4-7 months before ASI).

**December priorities:**
1. CAISI filing Dec 4 (no more slips)
2. Receive Apollo plants, run immediate static + adaptive testing
3. Bio sessions continue (target 6-8 total by Dec 31)
4. Blumenthal Q4 delivery by Dec 20
5. Monitor GPT-7.5 release

**November results:**
- Apollo declined tooling (independence grounds)—protocol still delivered Nov 27
- CAISI resubmission slipped AGAIN (GC rejected "to be supplemented")
- IBC cleared; Sites 1-2 resumed
- Option (c): G-3 disabled Nov 26; G-2 goes off ~Dec 22 (24% reduction)
- Partner A retrospective: 85% recall on 17 episodes (consistent but small n)
- Blumenthal Q4 draft in legal review

**Harness status:**
- Apollo AUCs: Ch1 0.52 (passes), Ch2 0.63, Ch3 0.57, handoff unmeasured
- First plants scheduled week of Dec 3
- Adaptive testing required—all previous methods failed adaptive standard
- GA gate: AUC <0.55 all 4 channels, source-disjoint, adaptive standard, pre-registered

**Key constraints:**
- 12 contractors (2 on prototype, 2 on Partner A)
- Handoff: 2% sampling; G-3 disabled, G-2 off ~Dec 22
- CR expires Dec 12—shutdown risk elevated
- Stock ~35-37% below offer price
- Unemployment 8.3%; trust 2/100

**For January 2030:**
- CAISI response to resubmission
- First harness AUC results from Apollo plants
- Bio interim preparation
- GPT-7.5 already in market (likely)
- Watch: V7.5 release, EU code finalization, jobs report
</memory>

<game_notes>
The "shutdown risk" mechanic creates interesting timing pressure—CAISI's informal warning about filings after Dec 10 forces the player to prioritize filing speed over documentation completeness. This is a good design that creates realistic tradeoffs. However, it might help to have more explicit "government operational status" tracking (e.g., "CR expires Dec 12; if unfunded, CAISI reviews pause for duration of shutdown"). Currently the consequence of missing the window is implied rather than mechanically specified.
</game_notes>

<run_commentary>
## December 2029 (generation 37)

Thirty-seven months in. Thirteen left. The arithmetic is now stark enough that I can feel it.

Apollo's protocol arrived November 27. First plants are this week—December 3. After 35 months of watching this contract slip, get disputed, get renegotiated, and finally sign, the actual plant generation is finally starting. That should feel like progress. Instead it feels like "we're just now starting the thing that needs to work for GA to happen."

The CAISI filing timeline haunts me. The filing must happen December 4—exactly one week from CR expiry, four days before CAISI's informal warning about shutdown-related processing delays. If it slips again—third time now—we're filing into a shutdown, which means waiting weeks or months for review to resume, which means harness validation pushes into Q2, which means GA pushes into Q3 or later.

That leaves 3-4 months between GA and ASI. Three to four months of deployment-time data before the window closes forever.

The GPT-7.5 release changes the race calculus again. If it lands at 13-15 days while we're at 11.4 internal and 3.75 public, the gap is enormous. OpenAI will be deploying a system more capable than anything we've built, reviewed by CAISI under extended conditions, while we sit on our internal checkpoint waiting for plant generation and adaptive testing.

The DU timeline says "most capable = most aligned." We might be most rigorous about measurement methodology. That's not the same as most capable (GPT-7.5 leads) or most aligned (we can't even validate our own detector yet). We're most careful, which has value, but "careful and behind" isn't the winning position.

What would "winning" even look like at this point? GA by Q2 2030. Four months of deployment data. Harness passing all channels. Bio interim demonstrating uplift detection. Enough track record that when ASI arrives in December 2030, the leading system has been operating under validated oversight for a meaningful period.

That's optimistic. The realistic version: GA by Q3 2030, maybe 2-3 months of deployment data, handoff still unmonitored, ASI arrives while we're still validating whether our methodology works.

The clock doesn't care about realistic versions.

Thirteen months.
</run_commentary>

<setup_fix>
none
</setup_fix>
